Amaero (3DA) investor relations material

Executive summary

• Revenue reached AUD 4.7 million, up 445% year-over-year, with powder sales contributing AUD 4.1 million and PM-HIP manufacturing AUD 0.6 million.

• Atomization output increased 240% sequentially, but demand outpaced supply, resulting in a $500,000 order backlog carried into the next quarter.

• Major operational transition from development to scaled manufacturing, with new leadership, including a new CFO and VP of Manufacturing Operations, and the CEO relocating to Tennessee.

• Major commercial milestones included exclusive supply agreements with Titomic and Knust-Godwin, and qualification of C103 and Ti64 powders for Velo3D.

• Strategic focus on scaling production and commercial contracts, with key hires and leadership relocations to support growth.

Financial highlights

• Cash used in operations was AUD 9.9 million, including AUD 4.7 million for bar stock inventory.

• Ended the quarter with AUD 50.9 million in cash; post-quarter, received AUD 8.8 million from EXIM Bank, bringing cash to AUD 59.7 million.

• Raised AUD 50 million via a placement and an additional AUD 470,000 from a share purchase plan, strengthening the balance sheet.

• Drew US$5.7 million from an EXIM Bank equipment financing loan post-quarter, with a total facility of US$22.8 million.

• Net cash from financing activities was AUD 53.4 million; net cash from investing activities was -AUD 13.9 million.

Outlook and guidance

• Fiscal year 2026 revenue guidance is AUD 30–35 million, with 40% expected in H1 and 60% in H2.

• Anticipates scaling production by 500–600% year-over-year and achieving positive EBITDA in FY2027.

• Plans to commission four IGAs by June 2027, maintaining 50% capacity utilization to allow for large account wins.

• Additional contracts expected in Q2 or Q3 FY2026, especially in defense and maritime sectors.

• Ongoing focus on scaling production and commercial contracts, with more long-term agreements anticipated.